These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 29328518

  • 1. Stevens-Johnson syndrome/toxic epidermal necrolysis overlap in a NSCLC patient treated with afatinib.
    Nühnen VP, Schön MP, Mössner R.
    J Dtsch Dermatol Ges; 2018 Feb; 16(2):199-201. PubMed ID: 29328518
    [No Abstract] [Full Text] [Related]

  • 2. Afatinib-induced toxic epidermal necrolysis: A case report with a literature review.
    Belančić A, Hlača N, Peternel S, Golčić M, Prpić-Massari L, Vlahović-Palčevski V.
    Br J Clin Pharmacol; 2024 Aug; 90(8):2030-2033. PubMed ID: 38803188
    [Abstract] [Full Text] [Related]

  • 3. Afatinib-associated Stevens-Johnson syndrome in an EGFR-mutated lung cancer patient.
    Doesch J, Debus D, Meyer C, Papadopoulos T, Schultz ES, Ficker JH, Brueckl WM.
    Lung Cancer; 2016 May; 95():35-8. PubMed ID: 27040849
    [Abstract] [Full Text] [Related]

  • 4. Pediatric Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Halted by Etanercept.
    Gavigan GM, Kanigsberg ND, Ramien ML.
    J Cutan Med Surg; 2018 May; 22(5):514-515. PubMed ID: 29421925
    [Abstract] [Full Text] [Related]

  • 5. Toxic epidermal necrolysis induced by vemurafenib after nivolumab failure.
    Arenbergerova M, Mrazova I, Horazdovsky J, Sticova E, Fialova A, Arenberger P.
    J Eur Acad Dermatol Venereol; 2017 May; 31(5):e253-e254. PubMed ID: 27739125
    [No Abstract] [Full Text] [Related]

  • 6. Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study.
    Auquier-Dunant A, Mockenhaupt M, Naldi L, Correia O, Schröder W, Roujeau JC, SCAR Study Group. Severe Cutaneous Adverse Reactions.
    Arch Dermatol; 2002 Aug; 138(8):1019-24. PubMed ID: 12164739
    [Abstract] [Full Text] [Related]

  • 7. [Stevens-Johnson syndrome and toxic epidermal necrolysis].
    Kaur-Knudsen D, Zachariae C, Thomsen SF.
    Ugeskr Laeger; 2013 Dec 09; 175(50):3096-9. PubMed ID: 24629532
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Toxic epidermal necrolysis induced by vemurafenib.
    Lapresta A, Dotor A, González-Herrada C.
    Actas Dermosifiliogr; 2015 Oct 09; 106(8):682-3. PubMed ID: 26051238
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Toxic epidermal necrolysis].
    Mao Martín L, Hernández Blanco C, Antolín Arias J, Cabello Carro J.
    Med Clin (Barc); 2008 Sep 13; 131(8):320. PubMed ID: 18803930
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Prendiville J.
    Adv Dermatol; 2002 Sep 13; 18():151-73. PubMed ID: 12528405
    [No Abstract] [Full Text] [Related]

  • 14. Toxic epidermal necrolysis in Stevens--Johnson syndrome.
    Assaad D, From L, Ricciatti D, Shapero H.
    Can Med Assoc J; 1978 Jan 21; 118(2):154-6. PubMed ID: 757383
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Pembrolizumab induced toxic epidermal necrolysis.
    Kumar R, Bhandari S.
    Curr Probl Cancer; 2020 Apr 21; 44(2):100478. PubMed ID: 31122669
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Management of drug-induced toxic epidermal necrolysis.
    Eisen ER, Fish J, Shear NH.
    J Cutan Med Surg; 2000 Apr 21; 4(2):96-102. PubMed ID: 11179933
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.